Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Febrile neutropenia"" wg kryterium: Temat


Tytuł:
"Better at home": Mixed methods report of intricacies in pediatric febrile neutropenia management.
Autorzy:
Smeallie ET; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
Choi SW; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.; Division of Pediatric Hematology Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Mody R; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.; Division of Pediatric Hematology Oncology, University of Michigan, Ann Arbor, Michigan, USA.
Guetterman TC; Rogel Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Department of Family Medicine, Mixed Methods Program, University of Michigan, Ann Arbor, Michigan, USA.
Nessle CN; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.; Division of Pediatric Hematology Oncology, University of Michigan, Ann Arbor, Michigan, USA.; Fogarty International Center, National Institute of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (6), pp. e7106.
Typ publikacji:
Journal Article
MeSH Terms:
Febrile Neutropenia*/etiology
Febrile Neutropenia*/therapy
Neoplasms*/complications
Child ; Humans ; Quality of Life ; Patient Discharge ; Hospitals
Czasopismo naukowe
Tytuł:
Gut diversity and the resistome as biomarkers of febrile neutropenia outcome in paediatric oncology patients undergoing hematopoietic stem cell transplantation.
Autorzy:
Sardzikova S; Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.
Andrijkova K; Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia.
Svec P; Department of Paediatric Haematology and Oncology, Children's Haematology and Oncology Clinic and Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
Beke G; Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia.
Klucar L; Institute of Molecular Biology, Slovak Academy of Sciences, Bratislava, Slovakia.
Minarik G; Medirex Group Academy N.P.O., Nitra, Slovakia.
Bielik V; Department of Biological and Medical Science, Faculty of Physical Education and Sport, Comenius University in Bratislava, Bratislava, Slovakia.
Kolenova A; Department of Paediatric Haematology and Oncology, Children's Haematology and Oncology Clinic and Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia.
Soltys K; Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Bratislava, Slovakia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 06; Vol. 14 (1), pp. 5504. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Febrile Neutropenia*
Neoplasms*
Child ; Humans ; Biomarkers ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Escherichia coli
Czasopismo naukowe
Tytuł:
Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock.
Autorzy:
Islas-Muñoz B; Infectious Diseases Department, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, 14000 Mexico City.
Volkow-Fernández P; Infectious Diseases Department, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, 14000 Mexico City.
Silva-Zamora J; Infectious Diseases Department, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, 14000 Mexico City.
Ramírez-Ibarguen A; Hematology Department, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, 14000 Mexico City, Mexico.
Cornejo-Juárez P; Infectious Diseases Department, Instituto Nacional de Cancerología (INCan), Alcaldía Tlalpan, 14000 Mexico City.
Pokaż więcej
Źródło:
Journal of infection in developing countries [J Infect Dev Ctries] 2024 Feb 29; Vol. 18 (2), pp. 235-242. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Shock, Septic*/epidemiology
Hematologic Neoplasms*/complications
Hematologic Neoplasms*/drug therapy
Neoplasms*/complications
Febrile Neutropenia*/microbiology
Humans ; Risk Factors ; Escherichia coli ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Pegfilgrastim on febrile neutropenia in pediatric and adolescent cancer patients: a systematic review and meta-analysis.
Autorzy:
Zhu X; Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, Beijing, People's Republic of China.
Zhang W; Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, Beijing, People's Republic of China.
Zhang Y; Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, Beijing, People's Republic of China.
Wang Y; Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, Beijing, People's Republic of China.
Hu H; Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, Beijing, People's Republic of China.
Li J; Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, Beijing, People's Republic of China.
Zhou Y; Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, Beijing, People's Republic of China.
Han T; Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, Beijing, People's Republic of China.
Huang D; Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, Beijing, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2172292.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Neoplasms*/complications
Neoplasms*/drug therapy
Febrile Neutropenia*/chemically induced
Febrile Neutropenia*/drug therapy
Febrile Neutropenia*/prevention & control
Humans ; Adolescent ; Child ; Filgrastim/therapeutic use ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Polyethylene Glycols ; Recombinant Proteins/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols
Czasopismo naukowe
Tytuł:
Febrile neutropenia incidence and the variable toxicity profile between brand and generic docetaxel in the adjuvant treatment of breast cancer with docetaxel and cyclophosphamide regimen.
Autorzy:
Tarcha FV; Instituto Brasileiro de Controle do Câncer , São Paulo , SP , Brazil .
Baccarin ALC; Instituto Brasileiro de Controle do Câncer , São Paulo , SP , Brazil .
Barros LADR; Instituto Brasileiro de Controle do Câncer , São Paulo , SP , Brazil .
Alencar EBA; Instituto Brasileiro de Controle do Câncer , São Paulo , SP , Brazil .
Del Giglio A; Centro Universitário FMABC , Santo André , SP , Brazil .
Cruz FJSM; Instituto Brasileiro de Controle do Câncer , São Paulo , SP , Brazil .; Centro Universitário FMABC , Santo André , SP , Brazil .
Pokaż więcej
Źródło:
Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2023 Dec 22; Vol. 21, pp. eAO0486. Date of Electronic Publication: 2023 Dec 22 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/pathology
Febrile Neutropenia*/chemically induced
Febrile Neutropenia*/drug therapy
Humans ; Middle Aged ; Female ; Docetaxel/adverse effects ; Retrospective Studies ; Incidence ; Taxoids/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/adverse effects ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Granulocyte Colony-Stimulating Factor/adverse effects
Czasopismo naukowe
Tytuł:
Blood plasma metagenomic next-generation sequencing for identifying pathogens of febrile neutropenia in acute leukemia patients.
Autorzy:
Qi Y; Department of Hematology, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China. .
Lin WQ; Department of Hematology, The First Hospital of Putian City, Putian, Fujian, China.
Liao B; Department of Hematology, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Chen JW; Department of Hematology, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Chen ZS; Department of Hematology, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 20; Vol. 13 (1), pp. 20297. Date of Electronic Publication: 2023 Nov 20.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/complications
Leukemia, Myeloid, Acute*/genetics
Febrile Neutropenia*/diagnosis
Humans ; Retrospective Studies ; High-Throughput Nucleotide Sequencing ; Metagenomics ; Plasma ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety.
Autorzy:
Moreno AF; Hematology Department, University Hospital Central of Asturias, Avenida Roma, 33011, Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias, Avenida Roma, 33011, Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias, C/ Fernando Bongera, 33006, Oviedo, Spain.
Lavín-Alconero L; Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.; Department of Clinical Pharmacology, Marqués de, Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.
de Ugarriza PL; Hematology Department, University Hospital Central of Asturias, Avenida Roma, 33011, Oviedo, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias, Avenida Roma, 33011, Oviedo, Spain.; Instituto Universitario de Oncología del Principado de Asturias, C/ Fernando Bongera, 33006, Oviedo, Spain.
Blanco LS; Hematology Department, Fundación Jiménez Díaz, Av. Reyes Católicos, 28040, Madrid, Spain.
Hernández SC; Hematology Department, San Pedro Alcántara Hospital, C/Pablo Naranjo Porras, 10003, Cáceres, Spain.
Burgués JMB; Hematology Department, San Pedro Alcántara Hospital, C/Pablo Naranjo Porras, 10003, Cáceres, Spain.
de Miguel MI; Hematology Department, San Pedro Alcántara Hospital, C/Pablo Naranjo Porras, 10003, Cáceres, Spain.
Huerta AJG; Hematology Department, University Hospital Central of Asturias, Avenida Roma, 33011, Oviedo, Spain.
Zarzuela MP; Hematology Department, University Clinic Hospital San Carlos, C/Prof. Martín Lagos, 28040, Madrid, Spain.
Boluda B; Hematology Department, Instituto de Investigación, University Hospital La Fe, Avinguda Fernando Abril Martorell, 46026, Valencia, Spain.
Humala K; Hematology Department, University Hospital La Paz, Paseo de La Castellana, 28046, Madrid, Spain.
Calabuig ML; Hematology Department, University Clinic Hospital of Valencia, Av Blasco Ibañez, 46010, Valencia, Spain.
Amigo ML; Hematology Department, University Hospital Morales Messeguer, C/Marqués de los Vélez, 30008, Murcia, Spain.
Casas MC; Hematology Department, University Hospital Carlos Haya, Av Carlos Haya, 29010, Malaga, Spain.
Del Mar García-Saiz M; Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.; Department of Clinical Pharmacology, Marqués de, Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.
Verdugo AF; Microbiology Department, University Hospital Central of Asturias, Avenida Roma, 33011, Oviedo, Spain.
Domínguez JF; Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.; Microbiology Department, University Hospital Central of Asturias, Avenida Roma, 33011, Oviedo, Spain.; CIBER_Enfermedades Respiratorias ISCIII, Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain.
Bernal T; Instituto Universitario de Oncología del Principado de Asturias, C/ Fernando Bongera, 33006, Oviedo, Spain. .; Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain. .; Department of Clinical Pharmacology, Marqués de, Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain. .; CIBER_Enfermedades Respiratorias ISCIII, Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, 28029, Madrid, Spain. .
Pokaż więcej
Źródło:
Trials [Trials] 2023 Oct 27; Vol. 24 (1), pp. 694. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Fosfomycin*/therapeutic use
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*
Febrile Neutropenia*/diagnosis
Febrile Neutropenia*/drug therapy
Humans ; Ciprofloxacin/adverse effects ; Anti-Bacterial Agents/adverse effects
Czasopismo naukowe
Tytuł:
Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study.
Autorzy:
Nara K; Department of Pharmacy, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. .
Yamamoto T; Department of Pharmacy, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.; The Education Center for Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Yamashita H; Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Yagi K; Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Takada T; Department of Pharmacy, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Seto Y; Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Suzuki H; Department of Pharmacy, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Oct 13; Vol. 23 (1), pp. 979. Date of Electronic Publication: 2023 Oct 13.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Stomach Neoplasms*
Febrile Neutropenia*/chemically induced
Febrile Neutropenia*/epidemiology
Humans ; Paclitaxel ; Oxaliplatin/adverse effects ; Retrospective Studies ; Neoplasm Recurrence, Local/drug therapy ; Esophagogastric Junction ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bilirubin ; Ramucirumab
Czasopismo naukowe
Tytuł:
Identifying Risk Factors and Improving Preventive Strategies for Febrile Neutropenia in Children with Leukemia Receiving Ciprofloxacin Prophylaxis
Autorzy:
Kaya Z; Gazi University Faculty of Medicine, Department of Pediatric Hematology, Ankara, Türkiye
Alıcı N; Gazi University Faculty of Medicine, Department of Pediatric Hematology, Ankara, Türkiye
Kırkız S; Gazi University Faculty of Medicine, Department of Pediatric Hematology, Ankara, Türkiye
Koçak Ü; Gazi University Faculty of Medicine, Department of Pediatric Hematology, Ankara, Türkiye
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 Aug 31; Vol. 40 (3), pp. 183-186. Date of Electronic Publication: 2023 Jun 14.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/complications
Leukemia, Myeloid, Acute*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Febrile Neutropenia*/etiology
Febrile Neutropenia*/prevention & control
Humans ; Child ; Ciprofloxacin/therapeutic use ; Risk Factors
Czasopismo naukowe
Tytuł:
Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia
Autorzy:
Erbaş İC; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Infectious Diseases, İzmir, Türkiye
Çakıl Güzin A; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Infectious Diseases, İzmir, Türkiye
Özdem Alataş Ş; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Infectious Diseases, İzmir, Türkiye
Karaoğlu Asrak H; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Infectious Diseases, İzmir, Türkiye
Akans İ; Dokuz Eylül University Faculty of Medicine, Department of Pediatrics, İzmir, Türkiye
Akyol Ş; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Hematology and Oncology, İzmir, Türkiye
Özlü C; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Infectious Diseases, İzmir, Türkiye
Tüfekçi Ö; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Hematology and Oncology, İzmir, Türkiye
Yılmaz Ş; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Hematology and Oncology, İzmir, Türkiye
Ören H; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Hematology and Oncology, İzmir, Türkiye
Belet N; Dokuz Eylül University Faculty of Medicine, Division of Pediatric Infectious Diseases, İzmir, Türkiye
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 Aug 31; Vol. 40 (3), pp. 143-153. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/complications
Leukemia, Myeloid, Acute*/drug therapy
Febrile Neutropenia*/etiology
Febrile Neutropenia*/complications
Child ; Humans ; Male ; Child, Preschool ; Female ; Retrospective Studies ; Acute Disease ; Risk Factors ; Anti-Bacterial Agents/therapeutic use
Czasopismo naukowe
Tytuł:
A Protocol for Low-Input RNA-Sequencing of Patients with Febrile Neutropenia Captures Relevant Immunological Information.
Autorzy:
Probst V; Department of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Smedegaard LM; Department of Paediatrics and Adolescent Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Simonyan A; Department of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Guo Y; Department of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Østrup O; Department of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Dungu KHS; Department of Paediatrics and Adolescent Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Vissing NH; Department of Paediatrics and Adolescent Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Nygaard U; Department of Paediatrics and Adolescent Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Bagger FO; Department of Genomic Medicine, Rigshospitalet, 2100 Copenhagen, Denmark.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 16; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 16.
Typ publikacji:
Journal Article
MeSH Terms:
Bacterial Infections*/drug therapy
Neoplasms*/genetics
Neoplasms*/drug therapy
Leukopenia*
Febrile Neutropenia*/diagnosis
Febrile Neutropenia*/genetics
Child ; Humans ; Prospective Studies ; Fever/drug therapy ; Anti-Bacterial Agents/therapeutic use ; RNA
Czasopismo naukowe
Tytuł:
D-index and invasive fungal infections (IFIs) in adult acute myeloid leukemia (AML) patients with the first episode of febrile neutropenia.
Autorzy:
Rattanathammethee T; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Munsamai K; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Punnachet T; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Hantrakun N; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Piriyakhuntorn P; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Hantrakool S; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Chai-Adisaksopha C; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Rattarittamrong E; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Tantiworawit A; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Norasetthada L; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 May 22; Vol. 18 (5), pp. e0286089. Date of Electronic Publication: 2023 May 22 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Invasive Fungal Infections*/drug therapy
Leukemia, Myeloid, Acute*/complications
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/microbiology
Febrile Neutropenia*/drug therapy
Humans ; Adult ; Antifungal Agents/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country.
Autorzy:
Joudeh N; Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Sawafta E; Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.
Abu Taha A; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. .; Department of Pathology, An-Najah National University Hospital, Nablus, 44839, Palestine. .
Hamed Allah M; Department of Hematology and Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine.
Amer R; Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. .; Department of Hematology and Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine. .
Odeh RY; Department of Hematology and Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine.
Salameh H; Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.; Department of Hematology and Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine.
Sabateen A; Infection Control Department, An-Najah National University Hospital, Nablus, 44839, Palestine.
Aiesh BM; Infection Control Department, An-Najah National University Hospital, Nablus, 44839, Palestine.
Zyoud SH; Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.; Poison Control and Drug Information Center (PCDIC), College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine.; Clinical Research Center, An-Najah National University Hospital, Nablus, 44839, Palestine.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Feb 22; Vol. 23 (1), pp. 106. Date of Electronic Publication: 2023 Feb 22.
Typ publikacji:
Journal Article
MeSH Terms:
Hematologic Neoplasms*/complications
Leukemia, Myeloid, Acute*/complications
Febrile Neutropenia*/complications
Febrile Neutropenia*/drug therapy
Male ; Humans ; Adult ; Middle Aged ; Female ; Anti-Bacterial Agents/therapeutic use ; Ceftazidime ; Amikacin ; Retrospective Studies ; Developing Countries ; Fever/etiology ; Piperacillin, Tazobactam Drug Combination
Czasopismo naukowe
Tytuł:
The microbial spectrum and antimicrobial resistance pattern in pediatric cancer patients with febrile neutropenia at King Abdullah University Hospital, Jordan.
Autorzy:
Alzu'bi, Diya (AUTHOR)
Obeidat, Hanady (AUTHOR)
Ghabashineh, Dua'a (AUTHOR)
AbuRass, Omayma (AUTHOR)
Musadag, Ola (AUTHOR)
Samara, Dua' N. (AUTHOR)
Al Droubi, Belal (AUTHOR)
Abdelhady, Gamal T. (AUTHOR)
Al-Sweedan, Suleimman (AUTHOR)
Pokaż więcej
Źródło:
Egyptian Pediatric Association Gazette. 3/8/2024, Vol. 72 Issue 1, p1-9. 9p.
Czasopismo naukowe
Tytuł:
Akut Myeloid Lösemi Hastaları İçin Kinolon Profilaksisinde Levofloksasin ve Moksifloksasin Kullanımının Prospektif Değerlendirmesi.
Autorzy:
Tekinalp, Atakan
Bağcı, Metin
Erayman, İbrahim
Demircioğlu, Sinan
Çeneli, Özcan
Dağlı, Mehmet
Pokaż więcej
Alternatywny tytuł:
A Prospective Observational Study: Levofloxacin or Moxifloxacin for Quinolone Prophylaxis in AML Patients?
Źródło:
Klimik Journal / Klimik Dergisi. Mar2024, Vol. 37 Issue 1, p54-58. 5p.
Czasopismo naukowe
Tytuł:
Predictive Model for Occurrence of Febrile Neutropenia after Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter, Retrospective, Observational Study.
Autorzy:
Morimoto, Masaya (AUTHOR)
Yokoya, Yuma (AUTHOR)
Yoshida, Kikuaki (AUTHOR)
Kosako, Hideki (AUTHOR)
Hori, Yoshikazu (AUTHOR)
Mushino, Toshiki (AUTHOR)
Tamura, Shinobu (AUTHOR)
Ito, Reiko (AUTHOR)
Koyamada, Ryosuke (AUTHOR)
Yamashita, Takuya (AUTHOR)
Mori, Shinichiro (AUTHOR)
Mori, Nobuyoshi (AUTHOR)
Ohde, Sachiko (AUTHOR)
Pokaż więcej
Źródło:
Hematology Reports. Mar2024, Vol. 16 Issue 1, p76-88. 13p.
Czasopismo naukowe
Tytuł:
Internal evaluation of risk stratification tool using serial procalcitonin and clinical risk factors in pediatric febrile neutropenia: The non-interventional, single institution experience prior to clinical implementation.
Autorzy:
Nessle CN; Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Braun T; School of Public Health, Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Choi SW; Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Mody R; Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Pokaż więcej
Źródło:
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2023 Mar; Vol. 40 (2), pp. 172-180. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*
Tool Use Behavior*
Febrile Neutropenia*/diagnosis
Humans ; Child ; Procalcitonin ; Cohort Studies ; Risk Factors ; Risk Assessment
Czasopismo naukowe
Tytuł:
Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review.
Autorzy:
Gebremariam GT; School of Pharmacy, Addis Ababa University, Zambia Street, P.O. box: 1176, Addis Ababa, Ethiopia. .
Fentie AM; School of Pharmacy, Addis Ababa University, Zambia Street, P.O. box: 1176, Addis Ababa, Ethiopia.
Beyene K; Department of Pharmaceutical and Administrative Sciences, University of Health Sciences and Pharmacy in St. Louis, St. Louis, USA.
Sander B; Institute of Health Policy, Management, and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario, M5T 3M6, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4, Canada.; Institute for Clinical Evaluative Sciences, 2075 Bayview Ave, Toronto, Ontario, M4N 3M5, Canada.; Public Health Ontario, 480 University Ave, Toronto, Ontario, M5G 1V2, Canada.
Gebretekle GB; Institute of Health Policy, Management, and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario, M5T 3M6, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, 200 Elizabeth Street, Toronto, Ontario, M5G 2C4, Canada.; Centre for Vaccine-Preventable Diseases, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2022 Dec 30; Vol. 22 (1), pp. 1600. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Chemotherapy-Induced Febrile Neutropenia*/drug therapy
Chemotherapy-Induced Febrile Neutropenia*/etiology
Chemotherapy-Induced Febrile Neutropenia*/prevention & control
Antineoplastic Agents*/adverse effects
Lymphoma*
Febrile Neutropenia*/chemically induced
Febrile Neutropenia*/prevention & control
Febrile Neutropenia*/drug therapy
Humans ; Filgrastim ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Cost-Benefit Analysis ; Polyethylene Glycols ; Recombinant Proteins ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Tytuł:
The role of presepsin in pediatric patients with oncological and hematological diseases experiencing febrile neutropenia.
Autorzy:
Cerasi S; Pediatric Oncology and Hematology 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Giuseppe Massarenti 11, 40138, Bologna, Italy.
Leardini D; Pediatric Oncology and Hematology 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Giuseppe Massarenti 11, 40138, Bologna, Italy. .
Lisanti N; Pediatric Oncology and Hematology 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Giuseppe Massarenti 11, 40138, Bologna, Italy.
Belotti T; Pediatric Oncology and Hematology 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Giuseppe Massarenti 11, 40138, Bologna, Italy.
Pierantoni L; Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy.
Zama D; Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy.
Lanari M; Pediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy.
Prete A; Pediatric Oncology and Hematology 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Giuseppe Massarenti 11, 40138, Bologna, Italy.
Masetti R; Pediatric Oncology and Hematology 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Giuseppe Massarenti 11, 40138, Bologna, Italy.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Apr 20; Vol. 13 (1), pp. 6464. Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:
Journal Article
MeSH Terms:
Hematologic Neoplasms*/complications
Hematologic Diseases*/complications
Bacterial Infections*/complications
Febrile Neutropenia*/etiology
Humans ; Child ; Lipopolysaccharide Receptors ; Peptide Fragments ; Biomarkers ; C-Reactive Protein/metabolism ; Fever/complications
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies